Cancer News

Check It Out: May is Skin Cancer Awareness Month (05/01/2017)

Skin cancer is the most commonly diagnosed cancer in the United States. Although the majority of skin cancers fall under basal cell and squamous cell carcinomas (number of cases estimated to be around 5 million), most deaths are a result of melanoma which accounts for approximately 1% of cases. In 2016, the ACS estimates 76,380 …

Continue reading "Check It Out: May is Skin Cancer Awareness Month"

Yervoy® Improves Overall Survival in Fully Resected Stage III Melanoma Patients (10/24/2016)

Results were presented during the 2016 European Society for Medical Oncology Congress demonstrating that Yervoy® (ipilimumab) compared to placebo improves survival in stage III melanoma patients who are at high risk of recurrence following complete surgical resection. In the study, Yervoy compared with placebo significantly improved overall survival (OS) with five-year OS rates at 65.4% … Continue reading "Yervoy® Improves Overall Survival in Fully Resected Stage III Melanoma Patients"

Epacadostat Plus Keytruda® Appears Effective in Melanoma (10/11/2016)

The treatment combination consisting of epacadostat plus Keytruda® (pembrolizumab) appears effective in the treatment of advanced melanoma. Melanoma is a type of skin cancer that often starts in the form of a mole. If detected and treatable with surgery, melanoma has a high cure rate. However, once melanoma invades deeper tissues or spreads from its … Continue reading "Epacadostat Plus Keytruda® Appears Effective in Melanoma"

Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma (09/20/2016)

The treatment combination consisting of Cotellic® (cobimetinib) plus Zelboraf® (vemurafenib) improves overall survival for patients with advanced, BRAF (V600) mutation-positive melanoma. These confirmatory results have led to this treatment combination being considered as a new standard of care for patients with this disease. These results were recently published in the Lancet Oncology. Melanoma is a … Continue reading "Cotellic®/Zelboraf® Combo: New Standard of Care for Melanoma"